[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212-220-6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 34, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 931133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Schond L. Greenway M.B.A.", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 608624, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 658522, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli M.B.A., Ph.D.", "age": 70, "title": "Executive President", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 552464, "exercisedValue": 0, "unexercisedValue": 1030416}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 66, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 313087, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1714521600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.4, "open": 8.43, "dayLow": 7.874, "dayHigh": 8.475, "regularMarketPreviousClose": 8.4, "regularMarketOpen": 8.43, "regularMarketDayLow": 7.874, "regularMarketDayHigh": 8.475, "beta": 2.482, "forwardPE": -5.129032, "volume": 888951, "regularMarketVolume": 888951, "averageVolume": 2404993, "averageVolume10days": 1066440, "averageDailyVolume10Day": 1066440, "bid": 7.92, "ask": 7.99, "bidSize": 100, "askSize": 100, "marketCap": 571385536, "fiftyTwoWeekLow": 2.41, "fiftyTwoWeekHigh": 12.22, "fiftyDayAverage": 9.4018, "twoHundredDayAverage": 5.244175, "currency": "USD", "enterpriseValue": 311647680, "floatShares": 33264197, "sharesOutstanding": 71872400, "sharesShort": 6924134, "sharesShortPriorMonth": 5865852, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.09819999, "heldPercentInsiders": 0.026700001, "heldPercentInstitutions": 0.25279, "shortRatio": 2.84, "shortPercentOfFloat": 0.0988, "impliedSharesOutstanding": 71872400, "bookValue": 1.901, "priceToBook": 4.182009, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -95732000, "trailingEps": -2.44, "forwardEps": -1.55, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "52WeekChange": 1.2489393, "SandP52WeekChange": 0.25262225, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "messageBoardId": "finmb_631045282", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.95, "targetHighPrice": 36.0, "targetLowPrice": 16.0, "targetMeanPrice": 23.86, "targetMedianPrice": 20.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 99704000, "totalCashPerShare": 2.412, "totalDebt": 14129000, "quickRatio": 3.092, "currentRatio": 3.221, "debtToEquity": 18.083, "returnOnAssets": -0.39837003, "returnOnEquity": -0.83589995, "freeCashflow": -25911250, "operatingCashflow": -64365000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-24"}]